Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, Hajer Ben Khadhra, Philippe Merle, Giuliana Amaddeo, Nathalie Ganne-Carrie, Christine Silvain, Jean-Marie Peron, Philippe Mathurin, Rodolphe Anty, Thomas Uguen, Thomas Decaens, Ghassan Riachi, Mohamed Bouattour, Aurore Baron, Jean-Pierre Bronowicki, Georges-Philippe Pageaux, Olivier Rosmorduc, Gérard Ducournau, Mélina Gilberg, Alexandre Tanang, Julien Dupin, Anika Gilbert-Marceau, Jean-Frédéric Blanc
BACKGROUND AND OBJECTIVES: Hepatocellular carcinoma epidemiological data are limited in France. The Epidemio Liver Immunotherapy Tecentriq outcome research (ELITor) retrospective study, based on real-world data from the Carcinome HépatocellulaIrE en France (CHIEF) French cohort of hepatocellular carcinoma patients, aimed to get insight into the treatment patterns, the sociodemographic, clinical, biological, and etiological characteristics, and the quality of life of patients with unresectable hepatocellular carcinoma...
August 14, 2023: European Journal of Gastroenterology & Hepatology